Relevium Technologies (TSXV:RLV.H) Debt-to-Equity : -1.29 (As of Mar. 2022)

View and export this data going back to 2012. Start your Free Trial

What is Relevium Technologies Debt-to-Equity?

Relevium Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was C$1.47 Mil. Relevium Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was C$0.00 Mil. Relevium Technologies's Total Stockholders Equity for the quarter that ended in Mar. 2022 was C$-1.14 Mil. Relevium Technologies's debt to equity for the quarter that ended in Mar. 2022 was -1.29.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Relevium Technologies's Debt-to-Equity or its related term are showing as below:

TSXV:RLV.H's Debt-to-Equity is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 0.48
* Ranked among companies with meaningful Debt-to-Equity only.

Relevium Technologies Debt-to-Equity Historical Data

The historical data trend for Relevium Technologies's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relevium Technologies Debt-to-Equity Chart

Relevium Technologies Annual Data

Trend

Dec12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Debt-to-Equity

Get a 7-Day Free Trial

1.52

0.56

0.54

50.20

-0.65

Relevium Technologies Quarterly Data
	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Mar22
Debt-to-Equity	Get a 7-Day Free Trial															88.26	-6.70	-3.63	-0.65	-1.29

Competitive Comparison of Relevium Technologies's Debt-to-Equity

For the Pharmaceutical Retailers subindustry, Relevium Technologies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Relevium Technologies's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Relevium Technologies's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Relevium Technologies's Debt-to-Equity falls into.

Relevium Technologies Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Relevium Technologies's Debt to Equity Ratio for the fiscal year that ended in Jun. 2021 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.197	+	0)	/	-4.904
	=	-0.65

Relevium Technologies's Debt to Equity Ratio for the quarter that ended in Mar. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.473	+	0)	/	-1.138
	=	-1.29

Relevium Technologies (TSXV:RLV.H) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Relevium Technologies Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Relevium Technologies's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Relevium Technologies (TSXV:RLV.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Relevium Technologies Inc (TSXV:RLV.H) » Definitions » Debt-to-Equity

Comparable Companies

TSXV:LOTA WAR:TGS NEOE:TREE XCNQ:IWIN BOM:513430 HEWA HKSE:02211 TSXV:KO SSY BOM:501477

Traded in Other Exchanges

N/A

Address

1000 Sherbrooke Street West, Suite 2700, Montreal, QC, CAN, H3A 3G4

Website

https://www.releviumtechnologies.com

Relevium Technologies Inc is a Canada based company operates in the health and wellness industry with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition, and operations of brands and businesses in the health and wellness markets including medical cannabis. Its operating segment includes Consumer Packaged Goods (CPG); Pediatric Biopharma and Corporate. The company generates maximum revenue from Consumer Packaged Goods segment.

Relevium Technologies (TSXV:RLV.H) Headlines

No Headlines